343 related articles for article (PubMed ID: 18757183)
1. Staphylococcus aureus bacteraemia of unknown primary source: where do we stand?
Saginur R; Suh KN
Int J Antimicrob Agents; 2008 Nov; 32 Suppl 1():S21-5. PubMed ID: 18757183
[TBL] [Abstract][Full Text] [Related]
2. Methicillin-resistant Staphylococcus aureus bacteraemia diagnosed at hospital admission: distinguishing between community-acquired versus healthcare-associated strains.
Tacconelli E; Venkataraman L; De Girolami PC; DAgata EM
J Antimicrob Chemother; 2004 Mar; 53(3):474-9. PubMed ID: 14762054
[TBL] [Abstract][Full Text] [Related]
3. Predisposing factors, disease progression and outcome in 430 prospectively followed patients of healthcare- and community-associated Staphylococcus aureus bacteraemia.
Forsblom E; Ruotsalainen E; Mölkänen T; Ollgren J; Lyytikäinen O; Järvinen A
J Hosp Infect; 2011 Jun; 78(2):102-7. PubMed ID: 21511366
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis and management of Staphylococcus aureus bacteraemia.
Mitchell DH; Howden BP
Intern Med J; 2005 Dec; 35 Suppl 2():S17-24. PubMed ID: 16271058
[TBL] [Abstract][Full Text] [Related]
5. Risk factors and mortality of healthcare-associated and community-acquired Staphylococcus aureus bacteraemia.
Bassetti M; Trecarichi EM; Mesini A; Spanu T; Giacobbe DR; Rossi M; Shenone E; Pascale GD; Molinari MP; Cauda R; Viscoli C; Tumbarello M
Clin Microbiol Infect; 2012 Sep; 18(9):862-9. PubMed ID: 21999245
[TBL] [Abstract][Full Text] [Related]
6. A prospective multicenter study of Staphylococcus aureus bacteremia: incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistance.
Chang FY; MacDonald BB; Peacock JE; Musher DM; Triplett P; Mylotte JM; O'Donnell A; Wagener MM; Yu VL
Medicine (Baltimore); 2003 Sep; 82(5):322-32. PubMed ID: 14530781
[TBL] [Abstract][Full Text] [Related]
7. Endocarditis: impact of methicillin-resistant Staphylococcus aureus in hemodialysis patients and community-acquired infection.
Kuo CB; Lin JC; Peng MY; Wang NC; Chang FY
J Microbiol Immunol Infect; 2007 Aug; 40(4):317-24. PubMed ID: 17712466
[TBL] [Abstract][Full Text] [Related]
8. Feedback to clinicians on preventable factors can reduce hospital onset Staphylococcus aureus bacteraemia rates.
Kok J; O'Sullivan MV; Gilbert GL
J Hosp Infect; 2011 Oct; 79(2):108-14. PubMed ID: 21741724
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology of capsular and surface polysaccharide in Staphylococcus aureus infections complicated by bacteraemia.
Roghmann M; Taylor KL; Gupte A; Zhan M; Johnson JA; Cross A; Edelman R; Fattom AI
J Hosp Infect; 2005 Jan; 59(1):27-32. PubMed ID: 15571850
[TBL] [Abstract][Full Text] [Related]
10. Community-associated MRSA (CA-MRSA): an emerging pathogen in infective endocarditis.
Millar BC; Prendergast BD; Moore JE
J Antimicrob Chemother; 2008 Jan; 61(1):1-7. PubMed ID: 17962214
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of community-acquired and health care-associated Staphylococcus aureus bacteremia in patients treated at the emergency department of a teaching hospital.
Liao CH; Chen SY; Chang SC; Hsueh PR; Hung CC; Chen YC
Diagn Microbiol Infect Dis; 2005 Oct; 53(2):85-92. PubMed ID: 16168612
[TBL] [Abstract][Full Text] [Related]
12. Clinical and molecular epidemiology of nursing home-associated Staphylococcus aureus bacteremia.
Lesse AJ; Mylotte JM
Am J Infect Control; 2006 Dec; 34(10):642-50. PubMed ID: 17161739
[TBL] [Abstract][Full Text] [Related]
13. Staphylococcus aureus bloodstream infections: risk factors, outcomes, and the influence of methicillin resistance in Calgary, Canada, 2000-2006.
Laupland KB; Ross T; Gregson DB
J Infect Dis; 2008 Aug; 198(3):336-43. PubMed ID: 18522502
[TBL] [Abstract][Full Text] [Related]
14. Staphylococcus aureus bacteremia: epidemiology, pathophysiology, and management strategies.
Naber CK
Clin Infect Dis; 2009 May; 48 Suppl 4():S231-7. PubMed ID: 19374578
[TBL] [Abstract][Full Text] [Related]
15. Staphylococcus aureus bacteremia.
Jensen AG
Dan Med Bull; 2003 Nov; 50(4):423-38. PubMed ID: 14694855
[TBL] [Abstract][Full Text] [Related]
16. Morbidity and mortality of Staphylococcal bacteremia in children.
Hakim H; Mylotte JM; Faden H
Am J Infect Control; 2007 Mar; 35(2):102-5. PubMed ID: 17327189
[TBL] [Abstract][Full Text] [Related]
17. Staphylococcus aureus bacteraemia with known sources.
Rubinstein E
Int J Antimicrob Agents; 2008 Nov; 32 Suppl 1():S18-20. PubMed ID: 18715760
[TBL] [Abstract][Full Text] [Related]
18. Enhanced surveillance of meticillin-resistant Staphylococcus aureus bacteraemia in a London teaching hospital.
Jeyaratnam D; Edgeworth JD; French GL
J Hosp Infect; 2006 Aug; 63(4):365-73. PubMed ID: 16765481
[TBL] [Abstract][Full Text] [Related]
19. Staphylococcus aureus bacteremia.
Akbar DH; Mushtaq MA; El-Tahawi AT; Bahnasy AA
Saudi Med J; 2000 Feb; 21(2):171-4. PubMed ID: 11533776
[TBL] [Abstract][Full Text] [Related]
20. Prospective study of 424 cases of Staphylococcus aureus bacteraemia: determination of factors affecting incidence and mortality.
Hill PC; Birch M; Chambers S; Drinkovic D; Ellis-Pegler RB; Everts R; Murdoch D; Pottumarthy S; Roberts SA; Swager C; Taylor SL; Thomas MG; Wong CG; Morris AJ
Intern Med J; 2001 Mar; 31(2):97-103. PubMed ID: 11480485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
